Expert consensus on the application of artificial liver blood purification system in the treatment of severe and critical COVID-19
The prevention and treatment of COVID-19 nationwide has entered a tackling phase. Effective treatment of severe and critically ill patients is the key to reducing the fatality of the disease. The artificial liver blood purification system can remove inflammatory factors, alleviate the damage of the inflammatory response to the body, and has important value for the treatment of severe COVID-19. Led by academician Li Lanjuan, based on the experience of treating patients across the country, integrating the opinions of experts from all over the country, the center summarized and formulated the consensus including the basic principles, treatment indications, relative contraindications, mode selection, monitoring indicators, and efficacy evaluation of artificial liver, which provides reference for treatment of severe COVID-19 patients..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:36 |
|---|---|
| Enthalten in: |
Linchuang Gandanbing Zazhi - 36(2020), 6, Seite 1228-1229 |
| Sprache: |
Chinesisch |
|---|
| Beteiligte Personen: |
National Clinical Research Center for Infectious Diseases [VerfasserIn] |
|---|
| Links: |
doaj.org [kostenfrei] |
|---|
| Themen: |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
DOAJ045262217 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ045262217 | ||
| 003 | DE-627 | ||
| 005 | 20230308091605.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230227s2020 xx |||||o 00| ||chi c | ||
| 035 | |a (DE-627)DOAJ045262217 | ||
| 035 | |a (DE-599)DOAJaf389f6806974b14a664b221b26ba79c | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a chi | ||
| 050 | 0 | |a RC799-869 | |
| 100 | 0 | |a National Clinical Research Center for Infectious Diseases |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Expert consensus on the application of artificial liver blood purification system in the treatment of severe and critical COVID-19 |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a The prevention and treatment of COVID-19 nationwide has entered a tackling phase. Effective treatment of severe and critically ill patients is the key to reducing the fatality of the disease. The artificial liver blood purification system can remove inflammatory factors, alleviate the damage of the inflammatory response to the body, and has important value for the treatment of severe COVID-19. Led by academician Li Lanjuan, based on the experience of treating patients across the country, integrating the opinions of experts from all over the country, the center summarized and formulated the consensus including the basic principles, treatment indications, relative contraindications, mode selection, monitoring indicators, and efficacy evaluation of artificial liver, which provides reference for treatment of severe COVID-19 patients. | ||
| 653 | 0 | |a Diseases of the digestive system. Gastroenterology | |
| 773 | 0 | 8 | |i In |t Linchuang Gandanbing Zazhi |d Editorial Department of Journal of Clinical Hepatology, 2017 |g 36(2020), 6, Seite 1228-1229 |w (DE-627)DOAJ000064300 |x 10015256 |7 nnns |
| 773 | 1 | 8 | |g volume:36 |g year:2020 |g number:6 |g pages:1228-1229 |
| 856 | 4 | 0 | |u https://doaj.org/article/af389f6806974b14a664b221b26ba79c |z kostenfrei |
| 856 | 4 | 0 | |u http://www.lcgdbzz.org/qk_content.asp?id=10816 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1001-5256 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1001-5256 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 36 |j 2020 |e 6 |h 1228-1229 | ||